High Wycombe, United Kingdom

Velocity Clinical Research, High Wycombe

Founded in 2019 as the first site of Egin Research and acquired by Velocity Clinical Research in 2022, the experienced team at Velocity’s dedicated research site in High Wycombe conducts Phase 2-4 clinical trials across a broad variety of indications, including Infectious Disease, Pulmonology, Vaccines, and Women’s Health. By developing strong working relationships with local communities and having close ties with networks of cooperating practices, Velocity’s High Wycombe staff provides fast, accurate patient enrollment support, even for diverse populations.

Our High Wycombe team is committed to being a resource for study volunteers, to providing the highest quality of patient care with compassion and kindness and to advancing medicine through research. With decades of research experience shared among our investigators in High Wycombe, Velocity will deliver the right patients, investigators, and research staff for your next research program.

Velocity Clinical Research, High Wycombe
Second Floor, Apollo Centre, Desborough Road, High Wycombe, Buckinghamshire HP11 2QW

Phone: +44 7748 505888

Find a Clinical Trial in High Wycombe
Browse current research studies in High Wycombe on VelocityClinicalTrials.eu.

High-Wycombe-United-Kingdom-Velocity-Clinical-Research-Site

About Velocity Clinical Research

155,000+ people have a joined a study at Velocity

Many people enjoy the study experience and have joined several clinical trials at Velocity.

Velocity has decades of research experience

With sites that were established as long ago as 1986, Velocity has experts who have supported clinical trials for decades.

Velocity studies are led by healthcare professionals

All clinical trials conducted at Velocity are overseen by the U.S. Food and Drug Administration (FDA).

Our experienced research team in High Wycombe

Every clinical trial is overseen by a Principal Investigator – a physician who is responsible for the rights, safety and welfare of the study participants. All physicians at Velocity are board certified in their specialty area(s) and all research staff is trained in clinical research regulations, including GCP and HIPAA. Our clinical research team in High Wycombe is dedicated to conducting quality research in a professional and caring environment.

  • Dr. Ahmed Elshashai

    Medical Director, Principal Investigator
    Ahmed Elshashai, MBBCh is a Senior Clinical Research Physician with Velocity Clinical Research in the United Kingdom. He holds an MBBCh (Bachelor of Medicine, Bachelor of Surgery) degree from the Faculty of Medicine at the University of Alexandria in Egypt. Dr. Elshashai has been working in the clinical research field since January 2016 and has extensive experience as both a Principal Investigator and Sub-Investigator on trials in various therapeutic areas, including respiratory, musculoskeletal, metabolic/endocrine, dermatology, cardiovascular, vaccine, women’s health, device, and migraine studies. Prior to his current role, he was a founder of Egin Research. Additionally, he worked as a Psychiatry Registrar and Core Psychiatry Trainee at Essex Partnership University NHS Foundation Trust in the United Kingdom, and as a General Practitioner in Alexandria, Egypt.

  • Shiva Muthiah

    Director, UK Operations
    Shiva Muthiah is an experienced clinical research professional with eight years of service in a variety of roles. She currently operates as the Director of UK Operations for the Velocity Clinical Research sites in High Wycombe and North London. Prior to Velocity, Shiva was a founder of Egin Research, which was later acquired by Velocity. Shiva managed one of the biggest sites for a leading Site Management Organization for over three years as the site gained global recognition. Additionally, Shiva lead a study start up for eight dedicated research sites across the United Kingdom. Shiva’s tenure has introduced her to many therapeutic areas including but not limited to Respiratory, Musculo-skeletal, Metabolic/Endocrine, Dermatology, Cardiovascular, Vaccine, Women’s Health, and Device studies. She will continue to utilize these experiences to grow Velocity’s presence across Europe.

  • Judith Mackay, MBBS PhD MRCP

    Principal Investigator
    After earning a PhD in Immunology, Dr. Mackay spent five years working in the pharmaceutical industry in clinical pharmacology and medical affairs. Since 2004, she has been involved in clinical trials in academic settings and with site organisations. She has extensive experience as an investigator in research areas including vaccine, cardiovascular disease, lipid lowering, hypertension, diabetes, obesity, Alzheimer’s disease, gastroenterology, migraine, osteoarthritis, osteoporosis, and dermatology studies. Her NHS general medicine experience includes registrar rotations in general medicine, gastroenterology, and nephrology. She has also worked at the associate specialist and honorary clinical consultant levels in respiratory medicine and cardiovascular disease prevention.

Sponsors and CROs

From the leading pharma companies, to the most pioneering biotech startups, Velocity supports those who are exploring new frontiers in human health. Whether you’re ready to conduct a single-site study or a complex, high-volume clinical trial, trust Velocity.

clinical research team

It all starts with people like you.

Without clinical trial participants, it would not be possible to create new medicines, treatments, and cures.